Aviance Capital Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,628
Closed -$1.75M 235
2019
Q3
$1.75M Buy
17,628
+8,938
+103% +$849K 0.51% 50
2019
Q2
$803K Sell
8,690
-4,704
-35% -$447K 0.22% 130
2019
Q1
$1.26M Sell
13,394
-12,729
-49% -$1.11M 0.36% 78
2018
Q4
$1.67M Sell
26,123
-11,694
-31% -$863K 0.59% 42
2018
Q3
$3.38M Buy
37,817
+12,159
+47% +$1.07M 0.82% 16
2018
Q2
$2.04M Buy
25,658
+6,322
+33% +$525K 0.59% 35
2018
Q1
$1.72M Buy
19,336
+1,549
+9% +$149K 0.52% 47
2017
Q4
$1.86M Buy
17,787
+1,460
+9% +$165K 0.61% 37
2017
Q3
$2.38M Sell
16,327
-2,270
-12% -$309K 0.81% 25
2017
Q2
$2.42M Buy
18,597
+591
+3% +$72.4K 0.78% 26
2017
Q1
$2.24M Sell
18,006
-2,265
-11% -$271K 0.82% 26
2016
Q4
$2.35M Sell
20,271
-4,710
-19% -$525K 0.83% 27
2016
Q3
$2.61M Buy
24,981
+2,910
+13% +$315K 0.92% 26
2016
Q2
$2.18M Buy
22,071
+3,985
+22% +$412K 0.8% 34
2016
Q1
$1.81M Sell
18,086
-2,665
-13% -$274K 0.63% 38
2015
Q4
$2.48M Buy
20,751
+2,236
+12% +$259K 0.85% 24
2015
Q3
$2M Buy
18,515
+855
+5% +$106K 0.82% 27
2015
Q2
$2.04M Buy
17,660
+8,285
+88% +$947K 0.76% 27
2015
Q1
$1.08M Buy
9,375
+1,555
+20% +$186K 0.4% 69
2014
Q4
$875K Buy
7,820
+345
+5% +$36.4K 0.33% 88
2014
Q3
$708K Buy
7,475
+125
+2% +$11.3K 0.27% 122
2014
Q2
$631K Sell
7,350
-200
-3% -$15.2K 0.25% 129
2014
Q1
$527K Sell
7,550
-1,000
-12% -$79.2K 0.22% 127
2013
Q4
$722K Sell
8,550
-1,940
-18% -$154K 0.3% 96
2013
Q3
$808K Hold
10,490
0.38% 69
2013
Q2
$614K Buy
+10,490
New +$631K 0.33% 86

Other funds holding CELG

Aviance Capital Partners's CELG Position: Q4 2019 in Review

Aviance Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,628 shares — an estimated $1.75M sold.

Aviance Capital Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.38M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Aviance Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Aviance Capital Partners sold 17,628 Celgene Corp shares in Q4 2019, an estimated $1.75M.
  • Aviance Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Aviance Capital Partners's Celgene Corp position peaked at $3.38M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Aviance Capital Partners's 13F filing for Q4 2019, filed 7 Feb 2020.